0001973141-23-000110.txt : 20230627 0001973141-23-000110.hdr.sgml : 20230627 20230627155235 ACCESSION NUMBER: 0001973141-23-000110 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230627 DATE AS OF CHANGE: 20230627 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 231047150 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: ONE MAIN STREET, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Epstein David M. CENTRAL INDEX KEY: 0001488668 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: OSI PHARMACEUTICALS, INC. STREET 2: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 144 1 primary_doc.xml 144 0001488668 XXXXXXXX LIVE 0001701541 Black Diamond Therapeutics, Inc. 001-39200 ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868 Epstein David M. Officer Common UBS Financial Services, Inc.

1000 Harbor Boulevard Weehawken NJ 0708

25000 167500.00 36512572 06/27/2023 NASDAQ Common 09/16/2016 Founder Shares Issuer N 25000 09/16/2016 N/A Y 06/27/2023 12/29/2022 /s/ UBS Financial Services Inc, as attorney-in-fact for David M. Epstein